SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-027934
Filing Date
2023-08-08
Accepted
2023-08-08 07:07:13
Documents
100
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K adc-20230630.htm   iXBRL 6-K 217821
2 EX-99.1 adc-20230630_d2.htm   iXBRL EX-99.1 1214264
3 EX-99.2 adct-20230630x6kex992.htm EX-99.2 296689
4 EX-99.3 adct-20230630ex993.htm EX-99.3 199803
10 image_4a.jpg GRAPHIC 20773
  Complete submission text file 0001628280-23-027934.txt   8881656

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adc-20230630.xsd EX-101.SCH 91215
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adc-20230630_cal.xml EX-101.CAL 79542
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adc-20230630_def.xml EX-101.DEF 330951
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adc-20230630_lab.xml EX-101.LAB 689660
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adc-20230630_pre.xml EX-101.PRE 496501
94 EXTRACTED XBRL INSTANCE DOCUMENT adc-20230630_htm.xml XML 1562775
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39071 | Film No.: 231149267
SIC: 2834 Pharmaceutical Preparations